We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

208 hedge funds and large institutions have $1.18B invested in Immunogen Inc in 2018 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 61 increasing their positions, 61 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

660% more call options, than puts

Call options by funds: $16.9M | Put options by funds: $2.22M

37% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 27

5% more funds holding

Funds holding: 198 → 208 (+10)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 61

3% less capital invested

Capital invested by funds: $1.22B → $1.18B (-$41.6M)

Holders
208
Holders Change
+10
Holders Change %
+5.05%
% of All Funds
4.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
37
Increased
61
Reduced
61
Closed
27
Calls
$16.9M
Puts
$2.22M
Net Calls
+$14.6M
Net Calls Change
+$14.6M

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$39.6M
2
ACH
ArrowMark Colorado Holdings
Colorado
+$18.5M
3
BlackRock
BlackRock
New York
+$10.1M
4
BNP Paribas Asset Management
BNP Paribas Asset Management
France
+$9.02M
5
Millennium Management
Millennium Management
New York
+$5.57M

Top Sellers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
-$22.5M
2
Franklin Resources
Franklin Resources
California
-$16.9M
3
O
OrbiMed
New York
-$13.8M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$11.6M
5
ClearBridge Investments
ClearBridge Investments
New York
-$10.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBI
101
Baxter Bros Inc
Connecticut
$292K – – –
SI
102
Stephens Inc
Arkansas
$270K +$274K +28,526 New
Parallax Volatility Advisers
103
Parallax Volatility Advisers
California
$269K +$273K +28,385 New
NIT
104
NumerixS Investment Technologies
British Columbia, Canada
$246K +$64.4K +6,700 +36%
AIM
105
Assured Investment Management
New York
$240K -$11.3K -1,171 -4%
Creative Planning
106
Creative Planning
Kansas
$229K +$183 +19 +0.1%
AT
107
Arden Trust
Delaware
$228K -$5.82K -605 -2%
XK
108
Xact Kapitalforvaltning
Sweden
$228K – – –
Legal & General Group
109
Legal & General Group
United Kingdom
$218K +$23K +2,392 +12%
USAA
110
United Services Automobile Association
Texas
$217K – – –
Group One Trading
111
Group One Trading
Illinois
$213K -$691K -71,879 -76%
Pacer Advisors
112
Pacer Advisors
Pennsylvania
$213K +$216K +22,520 New
JMPWA
113
JP Morgan Private Wealth Advisors
California
$203K -$4.91K -511 -2%
SAM
114
Sectoral Asset Management
Quebec, Canada
$199K +$202K +21,013 New
Invesco
115
Invesco
Georgia
$191K -$2.19M -227,620 -92%
Wellington Management Group
116
Wellington Management Group
Massachusetts
$185K -$2.19M -228,001 -92%
Public Employees Retirement Association of Colorado
117
Public Employees Retirement Association of Colorado
Colorado
$185K +$188K +19,585 New
EMG
118
Ellington Management Group
Connecticut
$179K +$182K +18,900 New
Fifth Third Bancorp
119
Fifth Third Bancorp
Ohio
$176K +$279 +29 +0.2%
Teacher Retirement System of Texas
120
Teacher Retirement System of Texas
Texas
$163K -$106K -10,994 -39%
RJFSA
121
Raymond James Financial Services Advisors
Florida
$163K +$12.2K +1,268 +8%
QT
122
Quantbot Technologies
New York
$158K +$69.4K +7,216 +75%
WI
123
WrapManager Inc
California
$155K +$1.04K +108 +0.7%
US Bancorp
124
US Bancorp
Minnesota
$150K -$404 -42 -0.3%
Canada Life
125
Canada Life
Manitoba, Canada
$149K – – –
3 4
5
6 7

IMGN Hedge Fund Activity: Q3 2018 in Review

208 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q3 2018, worth a combined $1.18B — down 3.4% from $1.22B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new IMGN positions and 27 closed out — a net gain of 10 holders — while 61 added to existing stakes and 61 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $39.6M. The largest seller was Capital Research Global Investors, cutting an estimated $22.5M.

  • 208 institutional investors held Immunogen Inc (IMGN) as of Q3 2018, up from 198 in Q2 2018.
  • Funds reported $1.18B of Immunogen Inc stock for Q3 2018, down 3.4% quarter-over-quarter.
  • 37 funds opened new Immunogen Inc positions in Q3 2018 and 27 closed out, a net change of +10 holders.
  • The largest Immunogen Inc buyer in Q3 2018 was Point72 Asset Management, an estimated $39.6M added.
  • The largest Immunogen Inc seller in Q3 2018 was Capital Research Global Investors, an estimated $22.5M sold.

Based on aggregated 13F filings for Q3 2018.